Mayo Clinic's Engineering and Therapeutics in Gastrointestinal Disease Lab is developing novel gastric remodeling to improve obesity and obesity-related metabolic conditions.

Mayo Clinic's Engineering & Therapeutics in Gastrointestinal Disease Lab is developing new ways to deliver gene therapy into organs through endoscopic procedures endoscopists already perform.

This story is one in a series marking International Women and Girls in Science Day. Join us as we celebrate some laboratory leaders taking research to new heights. Faranak Fattahi, PhD, grew up with ...

Gastrointestinal diseases can cause symptoms like heartburn, constipation, diarrhea, and abdominal pain. Functional GI diseases affect how the digestive system works without visible organ damage.

ESD is performed with a thin, flexible endoscope inserted through the mouth or rectum. Using miniature tools, clinicians inject fluid to lift a precancerous or early cancer lesion from surrounding ...

There’s an ongoing uncertainty among experts about whether neoadjuvant therapy or surgery first is best for patients with ...

Recent studies highlight how artificial intelligence and CRISPR-based molecular tools are reshaping gastrointestinal diagnostics, from intestinal tuberculosis to colon polyp detection. AI-assisted ...

Cristcot, a clinical-stage pharmaceutical company advancing targeted therapies for gastrointestinal diseases, today announced that the Company will present its abstract evaluating the impact of ...

Bhuwan Giri, MBBS, is an assistant professor within the Division of Gastrointestinal Surgery. Dr. Giri earned his medical degree from All India Institute of Medical Sciences in New Delhi, India. He ...

The UAB Department of Surgery is proud to announce that Daniel Chu, M.D., MSPH, FACS, FASCRS, will serve the Division of Gastrointestinal Surgery as division director, effective October 1, 2023. As ...